SMAD2 and neoplasm: Additionally, we developed novel LiPBAE nanoparticles that efficiently deliver miR-590-3p to established rGBM human xenografts and we identified miR-590-3p as potent tumor suppressor that simultaneously block multiple SMAD2/3 targets, induce tumor regression, and prolong animal survival.